← brief for 2026-08-11 · Slowing decline

Treatment outcomes and safety of telitacicept in reducing proteinuria and hematuria for refractory childhood IgA vasculitis nephritis

Key takeaways

This study reported how children with a hard-to-treat kidney inflammation did on a drug called telitacicept. It looked at whether the drug lowered protein and blood in the urine. Because there was no comparison group, it shows early promise, not proof.

Who did this work

Yue Xi (Beijing Children’s Hospital) · Nan Zhou (Beijing Children’s Hospital) · Qiang Sun (Beijing Children’s Hospital) · Chen Ling (Beijing Children’s Hospital) · Ying Liang (Beijing Children’s Hospital) · Lei Lei (Beijing Children’s Hospital) · Dan Wu (Beijing Children’s Hospital) · Zeping Cao (Beijing Children’s Hospital) · Xin Mo (Beijing Children’s Hospital) · Zhi Chen (Beijing Children’s Hospital)

Source

Paper · OpenAlex, CKD concept sweep (DB seed + weekly delta) · 2026-08-08
https://doi.org/10.1186/s40001-026-04954-0